John B. Ketchum - 05 Jun 2024 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Douglas Barry, as attorney-in-fact
Issuer symbol
TNGX
Transactions as of
05 Jun 2024
Transactions value $
$0
Form type
4
Filing time
07 Jun 2024, 17:13:29 UTC
Previous filing
31 Aug 2023
Next filing
09 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNGX Common Stock Award $0 +4,687 +46.9% $0.000000 14,687 05 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNGX Stock Option (Right to Buy) Award $0 +28,125 $0.000000 28,125 05 Jun 2024 Common Stock 28,125 $7.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
F2 This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.